Jazz Pharmaceuticals JAZZ Advertising
Advertising at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AdvertisingExpense.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's advertising.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's advertising?
- Jazz Pharmaceuticals (JAZZ) reported advertising of $26.4M in Q4 2025.
- How has Jazz Pharmaceuticals's advertising changed year-over-year?
- Jazz Pharmaceuticals's advertising decreased by 1.7% year-over-year, from $26.85M to $26.4M.
- What is the long-term trend for Jazz Pharmaceuticals's advertising?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's advertising has grown at a -10.1% compound annual growth rate (CAGR), from $161.5M to $105.6M.
- What does advertising mean?
- Total spending on marketing and promotional activities.
- How do you interpret advertising?
- Higher spending may indicate aggressive market expansion or new product launches, while lower spending could suggest cost-cutting or a mature product lifecycle.
- How does advertising compare across companies?
- Commonly reported by consumer-facing and specialty pharma firms to track marketing efficiency relative to revenue growth.